salk institute logo

Leadership

Board of Trustees

Salk Institute for Biological Studies - Leadership - Board of Trustees

Board of Trustees

The Board of Trustees is composed of proven leaders from the world’s business and non-profit communities who bring a range of skills and perspectives to the Institute. They are committed to science, innovation, high-quality research and supporting the Institute’s mission. Trustees are charged with monitoring Institute operations to ensure the organization fulfills its scientific and training efforts, while operating in a financially responsible manner.

Marna C. Whittington, PhD (Chair)

(Retired) Chief Executive Officer

Allianz Global Investors Capital
Delaware

Richard A. Heyman, PhD (Vice Chair)

Salk Alumnus
Executive Chairman

Metacrine
California

Markus Reinhard (Vice Chair)

Managing Director

NOMIS Foundation
Switzerland

Janelle Ayres, PhD

Professor

Gene Expression Laboratory
Molecular and Systems Physiology Laboratory
NOMIS Center for Immunobiology and Microbial Pathogenesis
Howard Hughes Medical Institute Investigator
Salk Institute Legacy Chair
Salk Institute
California

Wolfgang Busch, PhD

Professor

Plant Molecular and Cellular Biology Laboratory
Integrative Biology Laboratory
Hess Chair in Plant Science
Salk Institute
California

David Dolby

Director

Dolby Family Ventures, LP
California

Frederick J. Dotzler

Managing Director

De Novo Ventures
California

Jay Flatley

(Former) Executive Chairman

Illumina
California

Carol Gallagher, PharmD

Venture Partner

New Enterprise Associates
California

Edwin K. Hunter, JD

Trustee

Joe W. and Dorothy Dorsett Brown Foundation
Louisiana/Utah

Lyn Hutton

Investment Consultant

California

Amy Jacobs

Philanthropist

California

Sanjay K. Jha, PhD

Partner

Eclipse Ventures
California

Gerald Joyce, MD, PhD

President and Professor

Jack H. Skirball Center for Chemical Biology and Proteomics
Salk Institute
California

Mark Knickrehm

Former Group Chief Executive

Accenture Strategy
California

Benjamin H. Lewis, MD

Columbia University Medical Center
New York Presbyterian Hospital
New York

Daniel C. Lewis

Former President

Booz Allen Hamilton
California

Corinne Mentzelopoulos

Chairman and Chief Executive Officer

Château Margaux
France

Howard H. Newman, PhD

Chairman and CEO

Pine Brook Road Partners, LLC
New York

Frederik Paulsen, PhD

Chairman

Ferring International Center S. A.
Switzerland

Terry Rosen, PhD

Co-founder and CEO

Arcus Biosciences
California

Eric Sagerman

Strategic Advisor

California

Mary Jane Salk

Author and philanthropist

New York

Timothy M. Schoen

President and CEO

BioMed Realty
California

Reuben Shaw, PhD

Professor

Molecular and Cell Biology Laboratory
William R. Brody Chair
Salk Institute
California

Haeyoung Kong Tang, PhD

Philanthropist

California

Daniel Tierney

President

Wicklow Capital Inc.
Illinois

Irving Weissman, MD

Professor

Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research
Professor of Developmental Biology
Stanford University
California